Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Supplemental Balance Sheet Information

3 Months Ended

Mar. 31, 2024

4.	Supplemental Balance Sheet Information

Prepaid and Other Assets

Prepaid and other assets consist of the following (in thousands):

	March 31, 2024		December 31, 2023
Prepaids	$	1,471	$	997
Other		89		102
Total prepaids and other assets	$	1,560	$	1,099

Property and Equipment, net

Property and equipment held for use by category are presented in the following table (in thousands):

	March 31, 2024			December 31, 2023
Equipment		20		$	20
Furniture		5			5
Total property and equipment		25			25
Less accumulated depreciation		(25	)		(25	)
Property and equipment, net	$	—		$	—

Depreciation expense was zero and $1,000 during three months ended March 31, 2024 and 2023, respectively.

Accrued Expenses

Accrued expenses consist of the following (in thousands):

	March 31,		December 31,
	2024		2023
Payroll	$	427	$	753
Professional services		1,630		591
Research and development services and supplies		1,497		400
Other		95		71
Total	$	3,649	$	1,815